Schwabe Pharma - Kaloba Cough & Cold Relief Syrup - Pelargonium Sidoides Root Extract - Traditionally Used for Common Cold, Runny Nose, Sore Throat, Blocked Nose, Cough - Sugar Free – 100ml

Product Information

You may want to read it again or show it to your doctor, pharmacist or qualified healthcare practitioner. We conducted a randomized, double blind, placebo-controlled clinical trial of 106 children with acute cough to evaluate the efficacy and safety of KalobaTUSS ®, a paediatric cough syrup based on acacia honey and on Malva sylvestris extract, Inula helenium extract, Plantago major extract, and Helichrysum stoechas extract by using a validated 6 points Likert scale. Results Kaloba Pelargonium Cough & Cold Relief syrup is an orange to light brown syrup. However it is a natural product and therefore slight variations in colour and taste may occur. This product also contains the following ingredients: ml (approximately 20 drops) of Kaloba Oral Drops, solution contains 120 mg ethanol (alcohol) equivalent to 2.4 ml beer or 1.0 ml of wine.

Consult a doctor immediately if your condition does not improve within one week, in case of fever lasting for several days or in case of shortness of breath or blood in the sputum. Gastro-intestinal complaints such as stomach pain, heartburn, nausea or diarrhoea. Rare side-effects (affecting more than 1 in 10,000 but fewer than 1 in 1000 people) Parents often believe that the administration of honey to relieve cough and improve sleep quality at night is more desirable than the administration of drugs such as diphenhydramine or dextromethorphan. Moreover, evidence from some clinical studies support the use of honey to relieve cough. Results from a study comparing a single dose of honey, dextromethorphan and no treatment indicated that parents view honey as the most favourable treatment for symptomatic relief of nocturnal cough due to upper respiratory tract infection in children aged 2–18 years [ 10].

Common Uses

Malva sylvestris is a biennial–perennial herbaceous medicinal plant known as “common mallow” that is indigenous to North Brendler T, van Wyk BE. A historical, scientific and commercial perspective on the medicinal use of Pelargonium sidoides (Geraniaceae). J Ethnopharmacol. 2008;119(3):420–33. Limitations included a delay of up to 3 months between patients completing the trial and the qualitative interview, so some interview participants could not recall all details. When asking patients whether they preferred liquid or tablets in the qualitative interviews, each patient had only tried one of these options. They were not aware that the Cochrane review [ 30] suggests that the liquid may be more effective than tablets; knowing this may have changed their responses. Of the 134 randomised patients, 82 were allocated to liquid (Kaloba® [ n = 42] or placebo [ n = 40]) and 52 to tablets (Kaloba® [ n = 26] or placebo [n = 26]). During the study period, three patients chose to withdraw – two from the liquid Kaloba® group, one from the liquid placebo group. One patient in the Kaloba® tablet group died due to reasons unrelated to the trial. After completing the trial, four patients were found to have been ineligible because they were women of reproductive age who were using a contraceptive which was not included in the list of the “most effective” contraceptives specified in the protocol. None of these were or subsequently became pregnant during the trial or experienced any adverse events. As the details of their contraception were only confirmed after they had completed the trial, their data is included in the analyses below, as were the data of all the withdrawn patients. The CONSORT diagram is given in Fig. 1. No studies on the effect on the ability to drive and use machines have been performed. 4.8 Undesirable effects

Of the 127 eligible patients not randomised, in 69 cases this was because the patient declined, and 51 of these gave a reason. Most frequent were concerns about the medication (21/51 patients: 5 didn’t want a placebo; 5 were concerned about potential side-effects; 4 didn’t want to take more medicines; 2 didn’t want a herbal medicine; 2 did not want the liquid preparation; 1 did not want the tablets; 2 wanted antibiotics). Second most frequent (12/51) were patients who were too busy to participate or had personal circumstances which would make it difficult (planned holiday, unwell family member). Nine patients felt either that they were too unwell to take part [ 6] or that they were improving and didn’t need to take anything [ 2] or that taking part would make them too anxious [ 1]. Three patients stated that they just didn’t want to be involved in research. Five patients specifically mentioned that they wouldn’t be good at completing the diary and one would have had to travel to another branch surgery of his GP practice to be recruited. We conducted a phase II double-blind feasibility trial with UK GP practices cluster-randomised to give liquid or tablet preparation (for logistical reasons), and within each practice, eligible patients were individually randomised to Pelargonium sidoides root extract (EPs®7630 – Kaloba®) or matched placebo. The detailed protocol for this trial has already been published [ 33]. This trial adheres to CONSORT guidelines. Participants It is recommended to continue treatment for several days after symptoms have subsided to avoid relapse. If you have any questions, or are unsure about anything, please ask your doctor, pharmacist or qualified healthcare practitioner. Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine.Film-coating: Hypromellose 5 mPas, Macrogol 1500, iron oxide yellow E 172, iron oxide red E 172, titanium dioxide E 171, talc, simeticone, methylcellulose, sorbic acid. Transcripts were analysed using inductive thematic analysis, following the framework approach [ 37]. The transcripts were compared within and between each other to search for themes, which were then reviewed, defined and named. The analysis followed three key steps: A. In the case of geranium essential oil, you can dilute it with a carrier oil like sesame oil and apply it to the skin. It works well for spot treatments, itchy skins, acne. In addition, you can use it as a massage oil. However, some carrier oils cause an allergic reaction. Therefore, you should ensure that the carrier oil you’re using suits your skin. Q. Do Pelargonium sidoides help in treating common colds?